AMEX:VNRX

VolitionRx Limited Schedules First Quarter 2019 Earnings Conference Call and Business Update

AUSTIN, Texas, May 6, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE American:  VNRX) today announced it will host a conference call onThursday, May 9 at 8:30 a.m. Eastern time to discuss its financial and operating results for the first quarter of 2019 in addition to providing a business update. ...

2019-05-07 04:05 6283

VolitionRx Limited Hosts Capital Markets Day at the New York Stock Exchange and Issues Company Update Report

ISNES, Belgium, April 9, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") hosted a Capital Markets Day at the New York Stock Exchange today to update interested parties on its recent progress. Volition has also issued a Company Update Report; a downloadable version of w...

2019-04-10 05:17 10333

VolitionRx Limited Signs Memorandum of Understanding with Texas A&M University for Potential Collaboration to Develop Nu.QTM Veterinary Diagnostics

ISNES, Belgium, April 9, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") has executed a nonbinding Memorandum of Understanding ("MOU") through its wholly-owned subsidiary, Belgian Volition SPRL, withTexas A&M University, a member of The Texas A&M University System. Pur...

2019-04-09 20:30 10361

VolitionRx Limited Signs Memorandum of Understanding with Fosun Long March in China

ISNES, Belgium, March 28, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") has executed a nonbinding Memorandum of Understanding ("MOU") with Shanghai Fosun Long March Medical Science Co., Ltd. ("Fosun Long March") with an expectation of negotiating and entering into a ...

2019-03-28 22:48 9132

VolitionRx Limited to Present at Conferences in March & April 2019

ISNES, Belgium, March 25, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that its Executive Vice President, Investor Relations,Scott Powell, is scheduled to present at three conferences in March andApril 2019. During the conferences, Dr. Powell will ou...

2019-03-25 20:40 5680

VolitionRx Limited to Present at Conferences in the U.S. Next Week

ISNES, Belgium, March 15, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that its Chief Executive Officer, Mr.Cameron Reynolds, is scheduled to present at two conferences in the U.S. next week. During the conferences, Mr. Reynolds will outline Volition...

2019-03-15 20:30 4531

VolitionRx Limited Announces Full Fiscal Year 2018 Financial Results and Business Update

ISNES, Belgium, March 13, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the full fiscal year endedDecember 31, 2018. Volition management will host a conference call tomorrow,March 14, at 8:30a.m. U.S. Eastern...

2019-03-14 04:05 6085

VolitionRx Limited Schedules Full Year 2018 Earnings Conference Call and Business Update

ISNES, Belgium, March 7, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE American: VNRX) today announced it will host a conference call onThursday, March 14 at 8:30 a.m. Eastern time to discuss its financial and operating results for the fourth quarter and full year 2018, in conjunction with the f...

2019-03-07 21:30 8285

VolitionRx Limited to Expand its Nu.Q(TM) Trials to Veterinary Diagnostics

ISNES, Belgium, Oct. 4, 2018 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced very encouraging preliminary results from a proof of concept study using its Nu.Q™ diagnostic test in veterinary medicine at the 10th anniversary meeting of the Belgian Technology Mi...

2018-10-04 21:00 517

VolitionRx Limited Releases Video Featuring Interviews with its Scientific Advisory Board

ISNES, Belgium, Sept. 26 2018 /PRNewswire/ -- VolitionRx Limited (NYSE American: VNRX) ("Volition") today released a video featuring members of its Scientific Advisory Board (SAB). The video was taken at Volition's laboratories inBelgium during the last SAB meeting and features members of the SAB...

2018-09-26 21:00 413

VolitionRx Limited to Attend Multiple Conferences in September

ISNES, Belgium, Sept. 5, 2018 /PRNewswire/ -- VolitionRx Limited  (NYSE American: VNRX) today announced that its Chief Executive Officer,Cameron Reynolds and/or its Executive Vice President of Investor Relations,Scott Powell, are scheduled to attend and present at mul...

2018-09-05 20:30 493

VolitionRx Limited Announces Second Quarter 2018 Financial Results and Business Update

ISNES, Belgium, Aug. 13, 2018 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the quarter endedJune 30, 2018. Volition management will host a conference call to discuss these results and provide a further business u...

2018-08-14 04:05 885

Preliminary Data from Study Demonstrates 94% Accuracy in Detecting Aggressive Prostate Cancer

ISNES, Belgium, Aug. 13, 2018 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced preliminary data from a prospective, multi-centered Proof of Concept Study of 84 men into the utility of Volition's Nu.Q™ assays to diagnose men with high-grade prostate cancer. Vo...

2018-08-13 20:30 705

VolitionRx Announces $9 Million Private Placement

ISNES, Belgium, Aug. 8, 2018 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that it has entered into a definitive agreement with an existing accredited investor related to a private placement offering (PIPE) of 5 million shares of Volition common stock at a ...

2018-08-08 18:00 497

VolitionRx Limited Schedules Second Quarter 2018 Earnings Conference Call and Business Update

ISNES, Belgium, Aug. 7, 2018 /PRNewswire/ -- VolitionRx Limited (NYSE American: VNRX) today announced it will host a conference call onTuesday, August 14 at 8:30 a.m. Eastern time to discuss its financial and operating results from the second quarter of 2018, in conjunction with the filing of its...

2018-08-07 20:35 500

VolitionRx's First Research Use Only Product Is "On-The-Shelf" Today

ISNES, Belgium, Aug. 1, 2018 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that its first product the "Total Nu.Q™ Assay" research use only (RUO) kit, is ready and available for purchase through Active Motif, its Global Sales and Distribution Partner ( http...

2018-08-01 19:00 664

Volition Extends Global Reach of its Clinical Trial Program

ISNES, Belgium, July 10, 2018 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that it has added to its already impressive clinical trial program with the execution of additional agreements to conduct large-scale colorectal cancer research studies across the A...

2018-07-10 20:30 457

Volition Secures Additional $700,000 Non-Dilutive Funding from the Walloon Region

ISNES, Belgium, July 2, 2018 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that it has been awarded additional non-dilutive funding of approximately$700,000 from the Walloon Regional Government. Including this latest amount, Volition has received approximat...

2018-07-02 20:30 548

VolitionRx Limited to Attend the Bank of America Merrill Lynch 2018 Health Care Conference from May 15-17, 2018

ISNES, Belgium, May 14, 2018 /PRNewswire/ -- VolitionRx Limited (NYSE American: VNRX) ("Volition") today announced its participation in the Bank of America Merrill Lynch 2018 Health Care Conference being held fromMay 15-17, 2018 at the Encore Hotel inLas Vegas, NV. Scott Powell, Executive Vice ...

2018-05-14 21:00 864

VolitionRx Limited Announces First Quarter 2018 Financial Results and Business Update

ISNES, Belgium, May 10, 2018 /PRNewswire/ -- VolitionRx Limited (NYSE American: VNRX) ("Volition") today announced financial results and a business update for the first quarter endedMarch 31, 2018. Volition management will host a conference call tomorrow,May 11, at 8:30 a.m. U.S. Eastern Time to ...

2018-05-11 04:05 1100
12345